Location History:
- Mölndal, SE (2020)
- Gothenburg, SE (2021)
Company Filing History:
Years Active: 2020-2021
Title: Anna Matilda Angelica Pettersen: Innovator in Pharmaceutical Sciences
Introduction
Anna Matilda Angelica Pettersen is a prominent inventor based in Gothenburg, Sweden. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compounds and their applications.
Latest Patents
Anna holds 2 patents that showcase her expertise and creativity. Her latest patents include "Salts of IJAK inhibitors and methods of using the same," which relates to salts of compounds prepared as a xinafoate salt, along with pharmaceutically acceptable compositions and methods of use. Another notable patent is for a "Crystalline form of (1R,2R)-2-[4-(3-methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazin-3-yl)cyclohexanecarboxamide," which focuses on its use in the prevention or treatment of cardiovascular diseases.
Career Highlights
Anna is currently employed at AstraZeneca AB, where she continues to push the boundaries of pharmaceutical research. Her work has been instrumental in developing new therapeutic options for various health conditions.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues, including James Francis McCabe and Carl-Johan Aurell. These partnerships have enhanced her research and contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Anna Matilda Angelica Pettersen is a remarkable inventor whose work in pharmaceutical sciences has led to significant advancements. Her patents reflect her dedication to improving health outcomes through innovative research and development.